Cargando…
Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study
BACKGROUND: Gestational diabetes is a risk factor for perinatal complications; include shoulder dystocia, birth injuries such as bone fractures and nerve palsies. It is associated with later development of type 2 diabetes, the risk of macrosomia and other long-term health effects of infants born to...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521813/ https://www.ncbi.nlm.nih.gov/pubmed/28732072 http://dx.doi.org/10.1371/journal.pone.0181613 |
_version_ | 1783252042817470464 |
---|---|
author | Ngala, Robert Amadu Fondjo, Linda Ahenkorah Gmagna, Peter Ghartey, Frank Naku Awe, Martin Akilla |
author_facet | Ngala, Robert Amadu Fondjo, Linda Ahenkorah Gmagna, Peter Ghartey, Frank Naku Awe, Martin Akilla |
author_sort | Ngala, Robert Amadu |
collection | PubMed |
description | BACKGROUND: Gestational diabetes is a risk factor for perinatal complications; include shoulder dystocia, birth injuries such as bone fractures and nerve palsies. It is associated with later development of type 2 diabetes, the risk of macrosomia and other long-term health effects of infants born to diabetic mothers. The study assesses placental peptides and maternal factors as potential predictors of gestational diabetes among pregnant women. MATERIAL AND METHODS: A total of 200 pregnant women were recruited for the study, 150 pregnant women without pre gestational diabetes including 50 women with low risk factors of diabetes as controls and 50 other pregnant women with pregestational diabetes as control. Fasting blood glucose and the lipid profile were determined by enzymatic methods using Envoy(®) 500 reagents (Vital Diagnostics, USA). Glycated haemoglobin was assessed using the Cation Exchange resin method. Leptin and the Human Placenta Lactogen were assayed using the Sandwich-ELISA technique. Beta chorionic gonadotrophin, insulin, progesterone and estradiol were determined using chemilumiscence imunoassay technique on MAGLUMI 600 analyzer. Anthropometry, including BMI and blood pressure were also measured. RESULTS: Fasting plasma glucose (FBG), insulin, insulin resistance, glycated haemoglobin and Human Placenta Lactogen(HPL)were significantly (p<0.0001) increased in the pregestational diabetic women whereas progesterone and estradiol were significantly decreased. In the second trimester however, there was no significant difference (p>0.05) in estradiol, insulin, insulin resistance and HPL between the pregnant women who developed gestational diabetes and those who did not. Leptin, progesterone and FBG were significantly increased in those who developed GDM. The risk of developing gestational diabetes increased with overweight (OR = 1.76, P = 0.370) and family history of diabetes (OR = 2.18, P = 0.282). CONCLUSION: Leptin, progesterone, estradiol estimated in this study were increased in the gestational diabetes mellitus women and fairly predicted gestational diabetes in the non-diabetics pregnant women. Obesity, aging and family history of diabetes were strongly predictive of gestational diabetes. |
format | Online Article Text |
id | pubmed-5521813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55218132017-08-07 Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study Ngala, Robert Amadu Fondjo, Linda Ahenkorah Gmagna, Peter Ghartey, Frank Naku Awe, Martin Akilla PLoS One Research Article BACKGROUND: Gestational diabetes is a risk factor for perinatal complications; include shoulder dystocia, birth injuries such as bone fractures and nerve palsies. It is associated with later development of type 2 diabetes, the risk of macrosomia and other long-term health effects of infants born to diabetic mothers. The study assesses placental peptides and maternal factors as potential predictors of gestational diabetes among pregnant women. MATERIAL AND METHODS: A total of 200 pregnant women were recruited for the study, 150 pregnant women without pre gestational diabetes including 50 women with low risk factors of diabetes as controls and 50 other pregnant women with pregestational diabetes as control. Fasting blood glucose and the lipid profile were determined by enzymatic methods using Envoy(®) 500 reagents (Vital Diagnostics, USA). Glycated haemoglobin was assessed using the Cation Exchange resin method. Leptin and the Human Placenta Lactogen were assayed using the Sandwich-ELISA technique. Beta chorionic gonadotrophin, insulin, progesterone and estradiol were determined using chemilumiscence imunoassay technique on MAGLUMI 600 analyzer. Anthropometry, including BMI and blood pressure were also measured. RESULTS: Fasting plasma glucose (FBG), insulin, insulin resistance, glycated haemoglobin and Human Placenta Lactogen(HPL)were significantly (p<0.0001) increased in the pregestational diabetic women whereas progesterone and estradiol were significantly decreased. In the second trimester however, there was no significant difference (p>0.05) in estradiol, insulin, insulin resistance and HPL between the pregnant women who developed gestational diabetes and those who did not. Leptin, progesterone and FBG were significantly increased in those who developed GDM. The risk of developing gestational diabetes increased with overweight (OR = 1.76, P = 0.370) and family history of diabetes (OR = 2.18, P = 0.282). CONCLUSION: Leptin, progesterone, estradiol estimated in this study were increased in the gestational diabetes mellitus women and fairly predicted gestational diabetes in the non-diabetics pregnant women. Obesity, aging and family history of diabetes were strongly predictive of gestational diabetes. Public Library of Science 2017-07-21 /pmc/articles/PMC5521813/ /pubmed/28732072 http://dx.doi.org/10.1371/journal.pone.0181613 Text en © 2017 Ngala et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Ngala, Robert Amadu Fondjo, Linda Ahenkorah Gmagna, Peter Ghartey, Frank Naku Awe, Martin Akilla Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study |
title | Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study |
title_full | Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study |
title_fullStr | Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study |
title_full_unstemmed | Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study |
title_short | Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study |
title_sort | placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. a case-control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521813/ https://www.ncbi.nlm.nih.gov/pubmed/28732072 http://dx.doi.org/10.1371/journal.pone.0181613 |
work_keys_str_mv | AT ngalarobertamadu placentalpeptidesmetabolismandmaternalfactorsaspredictorsofriskofgestationaldiabetesinpregnantwomenacasecontrolstudy AT fondjolindaahenkorah placentalpeptidesmetabolismandmaternalfactorsaspredictorsofriskofgestationaldiabetesinpregnantwomenacasecontrolstudy AT gmagnapeter placentalpeptidesmetabolismandmaternalfactorsaspredictorsofriskofgestationaldiabetesinpregnantwomenacasecontrolstudy AT gharteyfranknaku placentalpeptidesmetabolismandmaternalfactorsaspredictorsofriskofgestationaldiabetesinpregnantwomenacasecontrolstudy AT awemartinakilla placentalpeptidesmetabolismandmaternalfactorsaspredictorsofriskofgestationaldiabetesinpregnantwomenacasecontrolstudy |